DatasetName,DSN1_M(331) DSN1_S(109) DSN1_S(122) DSN1_S(123) DSN1_S(125) DSN1_S(49) DSN1_S(509) DSN1_S(68) DSN1_S(75) DSN1_S(77),DSN1_S(107) DSN1_S(11) DSN1_S(12) DSN1_S(14) DSN1_S(25) DSN1_S(28) DSN1_S(30) DSN1_S(315) DSN1_S(33) DSN1_S(331) DSN1_S(41) DSN1_S(42) DSN1_S(52) DSN1_S(57) DSN1_S(58) DSN1_S(61) DSN1_S(65) DSN1_S(81) DSN1_S(86) DSN1_S(93)
RM2024_Intensity D4-1___3,,
RB2022_4_PostEndurance,,
FSO2013_Ratio M/L normalized Rep3,0.4117564667928459,0.5393203804788615
SR2019_MCF7_Biol_repl_3,,
RKK2015_IKKb(K44M)+TNF-α/IKKb(K44M),,
SR2019_LM2_Biol_repl_1,,
RCJD2014_15min_1,,
AS2011_Ratio H/L Normalized by Proteins Inhi_1,,
CK2022_7 16-1,,0.5395356644649636
NJH2025_Sub12_HIIT_Mid,,
AH2018_LFQ_IT_1_C,,0.5505986204327943
RKK2015_TNF-α/basal,,
JJ2018_Ratio H/M normalized pP2,,
NJH2025_Sub12_MICT_Pre,,
NJH2025_Sub7_MICT_Post,,
DL2023_control-3,,
ZX2022_Control Replicate 2,,0.5497546885464548
HS2024_6_B_T3,,
JW2015_Intensity pre1,,
IMM2018_normalised rep. int. Empty-3,,
AMK2021_30R_p5,,
FSO2013_Ratio M/L normalized Rep1,0.441910022708329,0.5512027858639241
SR2019_MDAMB231_Biol_repl_4,,
GF2025_P2_Sph,,0.5373045789837091
FSO2012_Ratio -/+ 3-MB-PP1 exp. wt2b,,
NJH2025_Sub13_HIIT_Mid,,
CP2009_Ratio M/L,,
NJH2025_Sub7_HIIT_Post,,
KBE2022_Log2_Ex_44_T,0.42866383155584414,0.5348211892168275
DB2022_Intensity L2,,
TM2022_mock.4h.C,,
AST2020_anti-CD3.2,,0.5531030327692527
CW2012_10 µM Erl/control Experiment 1 Replicate B,,
HS2024_7_B_N1,,
FSO2013_Ratio M/L normalized Rep1___1,,0.5482123576363085
SAS2015_AZD/DMSO_Exp3,,
RM2024_Intensity D0-2___3,,
RM2024_Intensity D6-1,,
RB2022_8_RecoverySprint,,
RB2022_5_PreEndurance,,
CKC2017_log2 normalized phosphoproteomics_30min_rep#2,,
EP2017_Untreated R#4 normalized log2 ratio,0.4275083676689414,0.5472981375867101
WZ2023_Pu_010_30min,0.4106954660009928,0.5591656305870797
AS2011_Ratio H/L Proteins RNAi_2,,
RB2022_4_PreStrength,,
NJH2024_Sub4_MICT_Post,,
AH2018_LFQ_M_1_X,,0.5640220044767992
RB2022_8_RecoveryEndurance,,
KBE2022_Log2_Ex_14_U,0.4244501816755594,0.5487657389875723
FSO2013_Ratio M/L normalized Rep3___3,,
AH2018_TMTMS3_1_C,0.4329682235913463,0.5561131020176762
JJ2018_Ratio H/L normalized___1,,
ZQ2022_C2,,
RB2022_5_PreSprint,,
PG2020_Intensity 8h_C,0.3869211667683347,0.5282076228149214
AH2018_SILAC_MR_2_N,0.4082240331010915,0.5554309692681041
MV2014_Ratio M/L normalized A1___2 (2 min),,
TM2022_S2.8h.B,,
MV2014_Ratio M/H normalized B3___1 (30 min),,
FSO2012_Ratio -/+ 3-MB-PP1 exp. as4a,,
RNJ2017_Log2_ratio_Tsup:Tstim_D2,,
RM2024_Intensity D6-1___2,,
NJH2025_Sub7_MICT_Mid,,
LY2019_P1+,,
AS2011_Ratio H/L Proteins Inhi_2,,
BS2014_Log2(Ratio H/L normalized),,
UK2020_HCM_2,,
FSO2013_Ratio H/L normalized Rep2___2,0.4187814329942789,0.5345569296550858
EP2017_Pervanadate R#3 normalized log2 ratio,0.4438779470491353,0.5462665142443143
RM2024_Intensity D4-3___3,,
RB2022_5_PreStrength,,
NJH2024_Sub4_MICT_Mid,,
TM2022_S2.4h.A,,
RB2022_5_PostStrength,,
GF2025_P6_Sph,,0.5422332904448703
RB2022_2_PreSprint,,
ZX2022_CB treated Replicate 3,,0.5487306654222719
RM2024_Intensity D6-2___3,,
WZ2023_Pe_025_10min,0.42182181516359185,0.5598718935652166
AS2011_Ratio H/L Normalized by Proteins RNAi_1,,
AST2020_anti-CD3+PDL2.1,,0.5537530343991561
KBE2022_Log2_Ex_34_U,0.4244172504734731,0.5375689788723784
WZ2023_Pu_005_10min,0.42562014724689795,0.561443932679817
AS2011_Ratio H/L RNAi_2_1,,
NJH2024_Sub9_HIIT_Mid,,
CK2022_9 40-1,,0.5337333034968071
KTGR2014_Ratio H L Normalized Rep1_Rapamycin_0_15,,
LG2023_GSK3α-1_intensity,,0.5382473436360049
WZ2023_Pu_025_30min,0.40978836123174006,0.5613447598733138
AH2018_SILAC_MR_2_X,0.4320793189651294,0.5616577017463424
HS2024_4_PD_T2,,
NJH2024_Sub4_HIIT_Pre,,
RB2022_2_RecoverySprint,,
AS2011_Ratio H/L Protein RNAi_1,,
RM2024_Intensity D2-1___2,,
CR2017_Ratio Replicate 1.4,0.4471939554785882,0.5468758835984696
FR2021_Norm.Intensity.B,,
RM2024_Intensity D6-2___1,,
YC2018_Log2(SKBR3-LR/SKBR3)_Rep.2-1,,
RB2022_5_PostSprint,,
EJN2021_3_Rest_Basal,,
CR2017_Ratio Replicate 1.3,0.43595257681904015,0.5445342885440889
AS2011_Ratio H/L Normalized by Protein RNAi_2,,
KTGR2014_Ratio-Rapa 7 mins,,
AMK2021_120R_p1,,
AH2018_SILAC_3_X,,0.5546424906654567
JJ2018_Ratio M/L normalized pP3,,
AH2018_SILAC_M_2_N,,0.554655946377184
HS2024_7_PD_T2,,
FSO2013_Ratio H/L normalized Rep1___1,,0.5526944296756214
AH2018_LFQ_1_C,,0.558216724530245
AS2011_Ratio H/L Normalized Inhi_1_3,,
KBE2022_Log2_Ex_28_T,0.4337641925743581,0.5485524043269276
HS2024_3_B_N1,,
RM2024_Intensity D4-2___3,,
WZ2023_Pe_025_30min,0.4232101613434951,0.5610005428752693
CK2022_11 40-1,,0.535442260563382
CW2012_10 µM Erl/control Experiment 3 Replicate B,,
AH2018_SILAC_2_X,,0.555904537625134
MV2014_Ratio H/M normalized A2___2 (2 min),,
AS2011_Ratio H/L RNAi_1_2,,
KS2014_Intensity E15_1,0.4322600728581422,0.5612944588129882
FSO2013_Ratio H/L normalized Rep2,0.41826678859319627,0.5453476913015128
WZ2023_Pu_005_20min,0.413546542518391,0.55998661942835
NJH2024_Sub10_MICT_Post,,
RM2024_Intensity D2-3___1,,
CR2017_Ratio Replicate 1.5,0.43804530213663506,0.5451022729464676
CW2012_10 µM Gef/control Experiment 2 Replicate B,,
HS2024_7_B_T3,,
CKC2017_log2 normalized phosphoproteomics_60min_rep#1,,
AS2011_Ratio H/L RNAi_1,,
JC2019_Normalised_intensity_A_TiOx_Testis_sample_URO0059,,
AH2018_LFQ_M_1_C,,0.5613138997291545
NJH2025_Sub7_MICT_Pre,,
SR2019_SKBR3_Biol_repl_2,,0.5333549200249426
HS2024_9_B_T2,,
KTGR2014_Ratio-AA 7 mins,,
MV2014_Ratio L/H normalized B3___3 (5 min),,
HS2024_3_PD_T1,,
FSO2013_Ratio M/L normalized Rep3___2,0.4125091472020504,0.5277757325418079
SR2019_BT549_Biol_repl_3,,
RCJD2014_20min_mean,,
FR2021_Norm.Intensity.H,,
RB2022_2_PreStrength,,
DB2022_LFQ intensity L1.2,,
HS2024_4_B_N1,,
KTGR2014_Ratio H M Normalized Rep2_Rapamycin_0_15,,
CK2022_1 16-1,,0.5405139656290172
CK2022_1 200-1,,0.5464703390763195
PG2020_Intensity Mock_10h_D,,0.5495822884531921
SR2019_MCF10A_Biol_repl_2,,
JJ2018_Ratio M/L normalized pP2___2,,
HS2024_6_PD_T1,,
JVO2010_Ratio M/L Normalized by Protein ThymON - Log2 G1/S,,
RB2022_6_RecoveryEndurance,,
FSO2012_Ratio -/+ 3-MB-PP1 exp. wt3b,,
EP2017_Mitotic R#2 normalized log2 ratio,0.43156444063548927,0.5502677790892244
RCJD2014_5min_1,,
RM2024_Intensity D4-1___1,,
DL2023_24h-1,,
YC2018_Log2(SKBR3-LR/SKBR3)_Rep.1-1,,
FSO2012_Ratio -/+ 3-MB-PP1 exp. as2b,,
TM2022_S2.4h.C,,
SAS2015_PLX/AZD_Exp2,,
CR2017_Ratio Replicate 3.3,0.4151563430619527,0.5692118912498441
PG2020_Intensity 2h_C,,0.5405090402784158
VOI2024_Veh2 di,,
ZX2022_CB treated Replicate 2,,0.547748529339798
KBE2022_Log2_Ex_8_T,0.4309223768382777,0.5506617152636704
NJH2025_Sub10_MICT_Post,,
HS2024_6_I_T3,,
RN2012_L11,0.41380393258358045,0.5327568272327945
AS2011_Ratio H/L Normalized Inhi_2_2,,
IMM2018_normalised rep. int. Empty-1,,
HS2024_5_PD_T1,,
AH2018_LFQ_M_2_C,0.4195529914204146,0.5484821223573266
CK2022_3 40-1,,0.5397115737256214
RBK2021_1260T Early,,
NJH2024_Sub4_HIIT_Post,,
HS2024_4_I_T1,,
YA2020_Reporter_intensity_Cancer_No.5,0.4137074514722074,
HH2022_Reporter intensity 8,0.4286099364362137,0.5437951854477316
ZQ2022_N2,,
FSO2012_Ratio -/+ 3-MB-PP1 exp. wt1b,,
FSO2013_Ratio H/L normalized Rep3___3,,
AH2018_TMTMS3_2_N,0.42796774089144474,0.546563335595782
EJN2021_5_Rest_Basal,,
NJH2025_Sub2_HIIT_Post,,
NJH2025_Sub1_MICT_Post,,
HS2024_9_B_T1,,
FSO2012_Ratio -/+ 3-MB-PP1 exp. wt1a,,
JAW2011_Ratio H/L LS2_1,,
JVO2010_Log2 Ratio H/M Normalized aphidicolin,,
NJH2024_Sub6_HIIT_Pre,,
AH2018_SILAC_3_N,,0.5534075931012797
YA2020_Reporter_intensity_Normal_No.1,0.40898566080397114,
HS2024_3_B_T1,,
JJ2018_Ratio H/L normalized___2,,
RM2024_Intensity D0-2,,
MV2014_Ratio M/L normalized B1___2 (5 min),,
RB2022_7_PostStrength,,
RB2022_1_PostEndurance,,
CR2017_Ratio Replicate 3,0.46408105249974685,0.5574903590505398
SR2019_Hs578T_Biol_repl_3,,
MV2014_Ratio L/H normalized B3___1 (5 min),,
RBK2021_1244T Early,,
RB2022_3_PostSprint,,
NJH2024_Sub13_MICT_Mid,,
KTGR2014_Ratio-AA 2 mins,,
GF2025_P7_Sph,,0.5356344072349776
HS2024_8_I_T3,,
CF2017_EOC 3,,
LATM2013_Normalized Log2 Ratio (Medium/Light) Forward,,
HS2024_6_PD_T3,,
DL2023_12h-2,,
RM2024_Intensity D6-3___1,,
FS2019_Ctr1,,
WZ2023_Pu_010_20min,0.4182828940423796,0.5592115203419168
AS2011_Ratio H/L_3,,
CK2022_1 40-1,,0.5389462919855896
RNJ2017_Log2_ratio_Tsup:Trest_D1,,
CK2022_8 16-1,,0.5405253221461153
KS2014_Intensity N3,0.4284441908370308,0.5715230641978086
RB2022_4_RecoveryEndurance,,
RB2022_5_RecoveryEndurance,,
JAW2011_Ratio H/L LS1a_2,,
NJH2024_Sub12_HIIT_Mid,,
AH2018_LFQ_IT_1_N,,0.5520859893135506
FSO2013_Ratio H/M normalized Rep2,0.4096115661393937,0.5349366359234464
RAM2015_Log2 A,0.41069768722943223,0.5589761585980806
HS2024_8_PD_T1,,
JJ2018_Ratio H/L normalized pP2,,
CF2017_OSE 27,,
KS2014_Intensity E15_2,0.43082399150228,0.5586673813043832
BS2014_Log2(Ratio H/L protein),,
PG2020_Intensity 8h_A,0.42169447241885194,0.5422910319433086
HS2024_7_I_T1,,
VOI2024_Veh3 di,,
RKK2015_TNF-α+SC-514/basal,,
SR2019_JIMT1_Biol_repl_1,,0.5394168727381313
HW2015_Ratio H/L normalized Exp2,,
HS2024_3_I_N1,,
AH2018_SILAC_M_3_X,,0.5553125407902522
NJH2024_Sub9_HIIT_Post,,
AS2011_Ratio H/L RNAi_1_3,,
GRW2016_Ratio H/L normalized SILAC 1___2,,
NJH2025_Sub1_HIIT_Pre,,
YC2018_Log2(SKBR3-LR/SKBR3)_Rep.1-2,,
NJH2024_Sub4_HIIT_Mid,,
VOI2024_0.1uM 2 h_1 di,,
KBE2022_Log2_Ex_6_T,0.4281757131866398,0.5422006456262406
RM2024_Intensity D4-3___1,,
AH2018_LFQ_4_X,0.40938004090979935,0.5564716231304555
AS2011_Inhi 2_Ratio H/L normalized by corresponding protein level (H:TAL treatment; L: MA treatment),,
RB2022_8_PostEndurance,,
NJH2025_Sub4_MICT_Mid,,
YP2020_Intensity C30_R1_mult_log2,,
AST2020_anti-CD3.1,,0.5535133533030977
NJH2025_Sub4_HIIT_Post,,
EP2017_Untreated R#4 log2 ratio,0.42748421733245817,0.5473041350601496
HS2024_6_B_N1,,
KBE2022_Log2_Ex_27_T,0.4207642234876901,0.5338467692844735
CW2012_10 µM Gef/control Experiment 1 Replicate A,,
VOI2024_0.1uM 24 h_1 mono,,
AMK2021_120R_p5,,
AS2011_Ratio H/L Proteins,,
NJH2024_Sub7_HIIT_Post,,
NJH2015_TMT Subject 1 127_N/126 (Exercise/Basal) (normalized),,
AS2011_Ratio H/L RNAi_2_2,,
RB2022_7_RecoveryStrength,,
AH2018_SILAC_IT_3_X,,0.556814267424073
JAW2011_Ratio H/L,,
PG2020_Intensity 10h_C,0.4204716969720848,0.533584978953235
FSO2013_Ratio M/L normalized Rep2,0.41163253357580354,0.5425785455535181
CP2009_Ratio H/M Normalized (50 nM dasatinib vs 5 nM dasatinib),,
HH2022_Reporter intensity 5,0.4304700070116826,0.5487769229368304
SR2019_HCC1954_Biol_repl_2,,
CK2022_14 40-1,,0.5416604976932511
RB2022_6_PreSprint,,
NJH2025_Sub12_MICT_Mid,,
PG2020_Intensity 4h_D,,0.5397323562064642
NJH2025_Sub2_MICT_Post,,
AH2018_LFQ_4_C,0.4069659388391453,0.5590257817895937
DL2023_control-1,,0.5318577299932163
AR2021_ALG 10 μM,,0.5527907075906985
JAW2011_Ratio H/L LS2_2,,
AH2018_SILAC_IT_3_N,,0.5529616568198645
EJN2021_4_Rest_Ins,,
RN2012_H05,,
NJH2024_Sub7_HIIT_Mid,,
GF2025_P2_Adh,,0.545021304807393
FSO2012_Ratio -/+ 3-MB-PP1 exp. as4b,,
RB2022_8_PostSprint,,
EJN2021_1_Rest_Ins,,
HH2022_Reporter intensity 3,0.41300156476114164,0.5493097569133588
FSO2012_Ratio -/+ 3-MB-PP1 exp. wt4b,,
AH2018_SILAC_IT_1_C,,0.5549435946091178
JW2021_After_3,,
GF2025_P8_Sph,,0.5441417361807865
FSO2012_Ratio -/+ 3-MB-PP1 exp. wt4,,
JJ2018_Ratio M/L normalized pP2___1,,
AH2018_SILAC_2_N,,0.5535091682978657
CK2022_11 200-1,,0.544175360129896
CK2022_12 200-1,,0.5449446395105306
AS2011_Ratio H/L Normalized by Protein RNAi_1,,
RM2024_Intensity D2-1___3,,
NJH2024_Sub1_MICT_Pre,,
HH2022_Reporter intensity 9,0.4221126467175827,0.5494979073428159
WZ2023_Su_010_20min,0.4096625706803104,0.5602544629828157
AH2018_TMTMS2_2_N,0.4335996102317079,0.559687285123849
NJH2024_Sub13_MICT_Pre,,
KBE2022_Log2_Ex_41_U,0.4289121537344724,0.5501222211936653
NJH2015_TMT Subject 3 129_N/128_C (Exercise/Basal) (normalized),,
AH2018_TMTMS3_Pool,0.4275031910316276,0.5475349196419538
KS2014_Intensity N4,0.4206678111982571,0.5474502169318103
NJH2024_Sub1_HIIT_Post,,
MM2018_Ratio H/L replicate2,,
RM2024_Intensity D4-2___2,,
NJH2024_Sub13_HIIT_Pre,,
CF2017_OSE 26,,
CK2022_14 200-1,,0.5519532462084165
SR2019_Hs578T_Biol_repl_1,,
RB2022_7_PostSprint,,
TM2022_mock.4h.A,,
NJH2025_Sub12_HIIT_Pre,,
AH2018_TMTMS3_1_N,0.4288700811892946,0.5512712080359958
AST2020_anti-CD3+PDL2.2,,0.5532087127697696
PG2020_Intensity Mock_10h_A,,0.5147054536045756
JW2021_After_2,,
NJH2024_Sub2_MICT_Post,,
EJN2021_2_Rest_Ins,,
SR2019_LM2_Biol_repl_4,,
CP2009_Ratio H/M,,
JAW2011_Ratio H/L HS,,
CK2022_13 16-1,,0.54397926700963
GF2025_P1_Adh,,0.5378202750411945
GF2025_P1_Sph,,0.5356123482489039
EJN2021_5_Ex_Basal,,
HS2024_7_I_T3,,
JJ2018_Ratio H/L normalized pP2___2,,
WZ2023_Pe_010_10min,0.43616532444683614,0.5637522916602998
CF2017_EOC 1,,
CK2022_3 200-1,,0.5460104527543427
AH2018_LFQ_IT_3_C,,0.5532931720801428
SR2019_Hs578T_Biol_repl_2,,
NJH2024_Sub12_HIIT_Post,,
JJ2018_Ratio H/L normalized pP1___2,,
MV2014_Ratio H/L normalized A1___2 (10 min),,
NJH2024_Sub10_MICT_Mid,,
NJH2024_Sub13_MICT_Post,,
BS2014_Log2(Ratio H/L normalized Rep_1),,
RB2022_3_RecoverySprint,,
NJH2025_Sub1_HIIT_Mid,,
RCJD2014_20min_2,,
FSO2012_Ratio -/+ 3-MB-PP1 exp. wt2,,
HS2024_6_PD_T2,,
HS2024_5_B_T1,,
CW2012_10 µM Gef/control Experiment 2 Replicate A,,
DL2023_12h-3,,0.5430826065658059
SR2019_MDAMB231_Biol_repl_2,,
HS2024_3_B_T2,,
RB2022_6_PreStrength,,
CK2022_2 40-1,,0.5396325679623886
RB2022_1_PostSprint,,
CK2022_4 200-1,,0.5457573039217578
JW2021_Before_2,,
TM2022_S2.12h.A,,
MV2014_Ratio L/M normalized B2___2 (30 min),,
CK2022_5 16-1,,0.5401119607503202
AR2021_ALG 1 μM,,0.5530039469875152
HS2024_4_B_T1,,
MV2014_Ratio M/H normalized A3___1 (10 min),,
SR2019_BT549_Biol_repl_4,,
EJN2021_1_Rest_Basal,,
NJH2025_Sub8_MICT_Post,,
RCJD2014_5min_3,,
CR2017_Ratio Replicate 3.2,0.43620692880880274,0.546717216414861
FSO2012_Ratio -/+ 3-MB-PP1 exp. as3a,,
GF2025_P7_Adh,,0.5380955970755974
CK2022_9 16-1,,0.5361158065293274
NJH2024_Sub6_HIIT_Post,,
AMK2021_30R_p3,,
AS2011_Ratio H/L Normalized RNAi_2,,
RM2024_Intensity D0-2___2,,
KS2014_Intensity pY_N4,,
CK2022_13 200-1,,0.5517614275941524
AS2011_Ratio H/L Normalized_2,,
PG2020_Intensity 6h_D,0.39901115274520976,0.5416792142285298
CK2022_16 16-1,,0.5437454571023221
FS2019_db/db3,,
CK2022_15 40-1,,0.5436475746170777
NJH2024_Sub9_MICT_Pre,,
BS2014_Log2(Ratio H/L unmodified peptide),,
WZ2023_Su_005_10min,0.41061152858510547,0.5585861476754869
RM2009_Ratio M/L (M:15 min timepoint;L:0 min. timepoint),,
KBE2022_Log2_Ex_41_T,0.4303475388021332,0.5456810620998047
AMK2021_Ctrl_p1,,
AH2018_LFQ_IT_3_X,,0.5558178459439658
HS2024_5_PD_T3,,
AH2018_TMTMS3_3_X,0.4243329799946783,0.5490434992118384
FSO2012_Ratio -/+ 3-MB-PP1 exp. as2,,
KBE2022_Log2_Ex_40_U,0.42565581720331513,0.5474155615230857
AH2018_LFQ_M_1_N,0.41642857219391416,0.5621658591476324
KBE2022_Log2_Ex_27_U,0.41851030628817537,0.5342010057698794
HW2015_Ratio M/L normalized Exp3,,
RKK2015_TNF-α/IKKb(K44M),,
AH2018_SILAC_M_1_N,,0.5491653812804377
HW2015_Ratio M/L normalized Exp1,,
RB2022_5_RecoveryStrength,,
YP2020_Intensity P10_R1_mult_log2,,
RB2022_7_PreStrength,,
YA2020_Reporter_intensity_Normal_No.4,0.404583433831834,
NJH2025_Sub13_HIIT_Pre,,
PG2020_Intensity CT_D,,0.5516475750915963
NJH2025_Sub9_MICT_Post,,
VOI2024_Veh1 mono,,
CK2022_12 16-1,,0.5375352671714049
RN2012_L13,,
LG2023_Control-1_intensity,,
RM2024_Intensity D6-3___2,,
KBE2022_Log2_Ex_8_U,0.4258756779629138,0.5509704143427294
SR2019_SKBR3_Biol_repl_3,,
NJH2024_Sub1_MICT_Post,,
HS2024_3_I_T2,,
KTGR2014_Ratio M L Normalized Rep2_Rapamycin_0_15,,
RM2024_Intensity D0-3___3,,
HS2024_6_I_T2,,
CW2012_10 µM Erl/control Experiment 2 Replicate B,,
AS2011_Ratio H/L Protein Inhi_1,,
FSO2013_Ratio H/M normalized Rep2___1,,0.5428114266932841
GRW2016_Ratio M/L normalized SILAC 5a___2,,
CK2022_10 40-1,,0.53432718137061
NJH2024_Sub12_HIIT_Pre,,
NJH2024_Sub8_MICT_Pre,,
RM2024_Intensity D0-1___1,,
LY2019_P3+,,0.5483690785482326
HH2022_Reporter intensity 6,0.4328580686161613,0.5480534643161776
RB2022_2_RecoveryStrength,,
KTGR2014_Ratio-AA 15 mins,,
AS2011_Ratio H/L Normalized RNAi_2_2,,
KS2014_Intensity pY_N3,,
MV2014_Ratio H/L normalized B1___2 (30 min),,
LY2019_P5-,,0.5434387977276539
HW2015_Ratio M/L normalized Exp2,,
SR2019_HCC1419_Biol_repl_1,,0.5422912127186216
AH2018_TMTMS2_3_X,0.43309752616388897,0.5599684542083844
GF2025_P3_Adh,,0.5427113792607288
SR2019_JIMT1_Biol_repl_2,,
AH2018_TMTMS2_1_C,0.4340740039480083,0.5609268336090519
RM2024_Intensity D0-1___2,,
LY2019_P4+,,0.5431625708313763
KBE2022_Log2_Ex_19_U,0.4240746241785051,0.5481883189725215
CKC2017_log2 normalized phosphoproteomics_0min_rep#1,,
RB2022_4_PostStrength,,
LG2023_GSK3α-3_intensity,,0.5466166161155439
YA2020_Reporter_intensity_Cancer_No.1,0.41983137369592427,
AST2020_Control,,0.5545224509293545
JAW2011_Ratio H/L LS1a,,
RCJD2014_5min_mean,,
NJH2015_iTRAQ Subject 4 114/115 (Exercise/Basal) (normalized),,
NJH2025_Sub1_MICT_Mid,,
TM2022_S2.12h.C,,
NJH2025_Sub9_MICT_Mid,,
CKC2017_log2 normalized phosphoproteomics_120min_rep#2,,
AS2011_Ratio H/L Normalized Inhi_1_2,,
FSO2013_Ratio M/L normalized Rep2___1,,0.5453881110470781
LG2023_Control-2_intensity,,
NJH2024_Sub8_HIIT_Pre,,
KS2014_Intensity pY_N2,,
RB2022_5_RecoverySprint,,
RB2022_7_RecoverySprint,,
YA2020_Reporter_intensity_Normal_No.3,0.40812778112371184,
HS2024_8_B_T2,,
AH2018_LFQ_1_X,,0.5580117219656235
RM2024_Intensity D6-1___1,,
RCJD2014_10min_2,,
FR2021_Norm.Intensity.M,,
RM2024_Intensity D0-3___1,,
KS2014_Intensity N2,0.40852242193348165,0.567497153133326
HH2022_Reporter intensity 1,0.4135915805839175,0.549538835511666
HH2022_Reporter intensity 2,0.4145932583585094,0.5489869755679362
RM2024_Intensity D6-2___2,,
FSO2012_Ratio -/+ 3-MB-PP1 exp. as1,,
RM2024_Intensity D2-3___2,,
YA2020_Reporter_intensity_Normal_No.5,0.4124097900352689,
SR2019_MCF7_Biol_repl_1,,
FSO2012_Ratio -/+ 3-MB-PP1 exp. as1a,,
HS2024_8_B_T1,,
NJH2025_Sub6_HIIT_Pre,,
RNJ2017_Log2_ratio_Tsup:Tstim_D1,,
EP2017_Untreated R#2 log2 ratio,0.42561114563201885,0.5768952977642969
SR2019_LM2_Biol_repl_3,,
RB2022_4_RecoveryStrength,,
CR2017_Ratio Replicate 2,0.4112647737800968,0.5461850556091359
CW2012_10 µM Erl/control Experiment 2 Replicate A,,
FSO2013_Ratio H/M normalized Rep3,0.41280891795196856,0.537294439197669
AR2021_KD 72h,,0.5779953510610513
MV2014_Ratio H/M normalized B2___3 (5 min),,
KBE2022_Log2_Ex_18_U,0.43178165570160604,0.5346599685887148
AS2011_Ratio H/L Inhi_1_1,,
NJH2024_Sub8_MICT_Post,,
AH2018_TMTMS3_3_C,0.42656334054121753,0.5509984144304496
KBE2022_Log2_Ex_9_U,0.4317332275944087,0.5394789657426902
AH2018_SILAC_M_3_N,,0.5541388616138888
KBE2022_Log2_Ex_13_T,0.4317389032282655,0.5496986419978797
RM2024_Intensity D0-3,,
SR2019_SKBR3_Biol_repl_1,,
PG2020_Intensity Mock_10h_C,,0.5362331500168865
CF2017_OSE 29,,
YB2013_Ratio_H_L_Normalized_in_experiment_1,,
NJH2025_Sub1_HIIT_Post,,
DL2023_24h-2,,
HS2024_7_B_N2,,
PG2020_Intensity 10h_A,0.420460592541781,0.5424566131501454
RN2012_L12,0.4325421850392406,0.5447913891277845
MV2014_Ratio M/L normalized B1___3 (5 min),,
NJH2024_Sub8_MICT_Mid,,
AH2018_LFQ_IT_4_C,,0.5532278992607523
SAS2015_PLX/AZD_Exp1,,
FR2021_Norm.Intensity.A,,
FSO2013_Ratio H/M normalized Rep1___1,,0.5481036091039803
JW2015_Intensity cap2,,
BS2014_Log2(Ratio H/L normalized Rep_2),,
NJH2024_Sub6_MICT_Post,,
CK2022_8 40-1,,0.5398224779600003
RB2022_7_RecoveryEndurance,,
NJH2025_Sub12_HIIT_Post,,
EJN2021_4_Ex_Basal,,
TM2022_S2.12h.B,,
RN2012_L15,0.4205983828432984,
KS2014_Intensity pY_PV3,,
TM2022_S2.4h.B,,
PG2020_Intensity 4h_A,,0.5477801570345722
FSO2013_Ratio H/M normalized Rep2___2,0.4104728241013326,0.5225042739952339
TM2022_mock.4h.B,,
KBE2022_Log2_Ex_24_U,0.4289040039666044,0.5411957465718368
NJH2025_Sub13_MICT_Mid,,
KS2014_Intensity C3,0.4396379337718136,0.5477199079583752
RB2022_1_PreSprint,,
HS2024_4_I_N1,,
CK2022_7 200-1,,0.5458254577938527
CK2022_5 200-1,,0.5472903149525418
CKC2017_log2 normalized phosphoproteomics_120min_rep#3,,
FSO2013_Ratio H/L normalized Rep2___1,,0.5470837523289095
NJH2024_Sub10_HIIT_Mid,,
RB2022_2_PostEndurance,,
AH2018_LFQ_2_C,0.4150464640344186,0.5558524466040942
AH2018_SILAC_MR_1_X,0.43109862872097426,0.5601797169626904
KTGR2014_Ratio H M Normalized Rep1_Rapamycin_0_15,,
IMM2018_normalised rep. int. Empty-2,,
RM2024_Intensity D4-1,,
KBE2022_Log2_Ex_25_U,0.42904090063290823,0.5567859531566159
AH2018_SILAC_3_C,,0.5532494768333016
EJN2021_5_Rest_Ins,,
VOI2024_0.1uM 24 h_3 di,,
RNJ2017_Log2_ratio_Tstim:Trest_D3,,
DB2022_LFQ intensity L2.1,,
FSO2013_Ratio H/M normalized Rep1,0.4223003874773264,0.5478421637200357
CK2022_4 16-1,,0.5400288698046681
AS2011_Ratio H/L,,
SR2019_MCF7_Biol_repl_4,,
EJN2021_2_Ex_Ins,,
AS2011_Ratio H/L Inhi_2_3,,
JAW2011_Ratio H/L LS1a_1,,
AH2018_LFQ_1_N,,0.5580500443298022
SAS2015_PLX/DMSO_Exp1,,
SFR2015_HL_log2_ratio_avg_c,,
JJ2018_Ratio M/L normalized pP2,,
NJH2024_Sub7_MICT_Mid,,
PG2020_Intensity 6h_B,0.41705879447493066,0.5434917136415202
FSO2013_Ratio H/L normalized Rep3,0.42071054580329853,0.5415882200878678
GRW2016_Ratio H/L normalized SILAC 2___2,,
RKK2015_IKKb(K44M)+TNF-α/TNF-α,,
JJ2018_Ratio M/L normalized,,
KTGR2014_Ratio-AA 30 mins,,
JW2021_After_1,,
NJH2025_Sub2_MICT_Mid,,
HS2024_6_B_N2,,
KBE2022_Log2_Ex_9_T,0.43194629831436704,0.5379584867171865
AH2018_SILAC_IT_2_N,,0.5544924403867849
AH2018_SILAC_IT_1_X,,0.5564799524123207
HW2015_Ratio H/L normalized Exp3,,
HS2024_7_PD_T1,,
UK2020_UA_2,,
RM2024_Intensity D2-1___1,,
GF2025_P10_Sph,,0.5405208624787095
WZ2023_Pe_025_20min,0.4208390638347198,0.561275963859738
JVO2010_Log2 Ratio M/L Normalized aphidicolin,,
AH2018_LFQ_2_N,,0.5586840273913714
HS2024_4_I_N2,,
AH2018_TMTMS2_3_N,0.43356949721230187,0.5620062801924999
RN2012_H06,0.42761790652121184,
AS2011_Inhi 1_Ratio H/L normalized by corresponding protein level (H:TAL treatment; L: MA treatment),,
HS2024_4_PD_T3,,
WZ2023_Su_005_30min,0.40614287887274997,0.559418066373612
SR2019_HCC1419_Biol_repl_4,,
JJ2018_Ratio H/M normalized___2,,
SR2019_JIMT1_Biol_repl_3,,0.5421369464361939
AS2011_Ratio H/L Protein,,
UK2020_HCM_3,,
NJH2024_Sub10_HIIT_Post,,
CR2017_Ratio Replicate 3.1,0.44495663330399343,0.5584329555265284
WZ2023_Su_025_10min,0.41870610404076825,0.5592654834658501
AH2018_LFQ_IT_4_X,,0.5546183111330056
CP2009_Ratio H/L,,
VOI2024_0.1uM 24 h_3 mono,,
RB2022_4_RecoverySprint,,
RM2024_Intensity D6-3,,
WZ2023_Su_005_20min,0.4137373894561514,0.5598253538053658
CW2012_10 µM Gef/control Experiment 1 Replicate B,,
SFR2015_HL_log2_ratio_avg_a,0.4257868510620012,0.5506381611257175
CW2012_10 µM Erl/control Experiment 3 Replicate A,,
RB2022_1_PreEndurance,,
FSO2012_Ratio -/+ 3-MB-PP1 exp. wt3a,,
LG2023_GSK3α-2_intensity,,0.544976430556223
EP2017_Pervanadate R#1 log2 ratio,0.44422973911606894,0.5409404397784913
NJH2025_Sub6_HIIT_Post,,
RB2022_6_RecoverySprint,,
KS2014_Intensity,0.4291234800925894,0.5831790645028969
MV2014_Ratio H/M normalized A2___1 (2 min),,
PG2020_Intensity 8h_D,0.4195536826322477,0.5307867990599103
LY2019_P7+,,0.5510348593050358
EP2017_Untreated R#1 normalized log2 ratio,0.43575719228556453,0.5301563997127696
RN2012_L10,0.4056195020761361,
PG2020_Intensity 4h_C,,0.5454823233283899
EP2017_Mitotic R#3 normalized log2 ratio,0.43027815961295046,0.5499320097251554
FSO2012_Ratio -/+ 3-MB-PP1 exp. as4,,
DB2022_LFQ intensity L1,,
KBE2022_Log2_Ex_24_T,0.4292422291448698,0.5370553163932962
RB2022_8_PostStrength,,
AH2018_SILAC_IT_2_X,,0.5564026688716833
HS2024_4_B_T3,,
NJH2024_Sub2_HIIT_Post,,
HS2024_8_B_N2,,
NJH2025_Sub8_HIIT_Pre,,
JJ2018_Ratio H/L normalized pP2___1,,
HS2024_8_I_T2,,
KBE2022_Log2_Ex_6_U,0.4222917040265958,0.5413890732556312
LATM2013_Normalized Log2 Ratio (Light/Medium) Reverse,,
CR2017_Ratio Replicate 1.1,0.4294004603801018,0.5437011632125317
CKC2017_log2 normalized phosphoproteomics_30min_rep#1,,
MV2014_Ratio M/H normalized B3___2 (30 min),,
CK2022_16 200-1,,0.5519248009824985
VOI2024_0.1uM 2 h_3 di,,
EP2017_Mitotic R#1 normalized log2 ratio,0.4335083210259169,0.5428288237260428
GF2025_P9_Sph,,0.5436389298972835
CK2022_6 200-1,,0.5461263501616351
NJH2024_Sub7_MICT_Post,,
AH2018_TMTMS3_2_X,0.42653081115612534,0.5525115546202092
NJH2024_Sub8_HIIT_Post,,
DB2022_LFQ intensity R1,,
JW2015_Intensity cap3,,
SR2019_HCC1954_Biol_repl_1,,
HS2024_4_I_T2,,
NJH2024_Sub2_MICT_Mid,,
VOI2024_0.1uM 2 h_2 mono,,
CP2009_Ratio M/L Normalized (5 nM dasatinib vs Ctrl),,
FSO2012_Ratio -/+ 3-MB-PP1 exp. as3b,,
HS2024_4_PD_T1,,
SAS2015_AZD/DMSO_Exp1,,
NJH2024_Sub1_MICT_Mid,,
IMM2018_normalised rep. int. CDK5L-3,,
HS2024_3_B_T3,,
MV2014_Ratio L/H normalized A3___2 (2 min),,
NJH2025_Sub13_MICT_Pre,,
SR2019_MDAMB231_Biol_repl_3,,
GRW2016_Ratio H/L normalized SILAC 4___1,,
MM2018_Ratio H/L replicate1,,
PG2020_Intensity 2h_D,,0.5447368909047039
EP2017_Untreated R#3 normalized log2 ratio,0.43163559089050363,0.5093932579836841
MV2014_Ratio M/H normalized A3___3 (10 min),,
NJH2024_Sub7_HIIT_Pre,,
JAW2011_Ratio H/L LS2,,
CK2022_8 200-1,,0.5466642685458669
KS2014_Intensity pY_C4,,
CR2017_Ratio Replicate 3.5,0.4089686356391712,0.5374585866846983
RB2022_7_PostEndurance,,
NJH2025_Sub4_HIIT_Pre,,
CKC2017_log2 normalized phosphoproteomics_90min_rep#3,,
TM2022_mock.12h.A,,
JJ2018_Ratio H/L normalized pP1,,
EP2017_Pervanadate R#2 normalized log2 ratio,0.44578243756255437,0.5606504087555407
AS2011_Ratio H/L Normalized by Protein (Unnormalized),,
KS2014_Intensity pY_E5_4,,0.5364197966758925
RM2024_Intensity D4-3___2,,
CKC2017_log2 normalized phosphoproteomics_15min_rep#1,,
AH2018_SILAC_2_C,,0.5533509282225468
AS2011_RNAi 2_Ratio H/L normalized by corresponding protein level (H: shPlk1; L: shEg5),,
HS2024_7_I_N1,,
KBE2022_Log2_Ex_29_T,0.4303777952683284,0.5377096742481824
HS2024_7_I_T2,,
AS2011_Ratio H/L Normalized RNAi_2_3,,
CW2012_10 µM Gef/control Experiment 3 Replicate B,,
HS2024_6_B_T2,,
AMK2021_45I_p5,,
CW2012_10 µM Erl/control Experiment 1 Replicate A,,
SAS2015_PLX/DMSO_Exp2,,
EJN2021_1_Ex_Basal,,
FR2021_Intensity.M,,
RB2022_2_PostSprint,,
AH2018_SILAC_MR_3_N,0.43257746616058546,0.5532273970899549
MV2014_Ratio H/L normalized B1___3 (30 min),,
CF2017_FTE 13,,0.544609239082784
PG2020_Intensity CT_C,,0.546723605016413
ZCP2016_Ratio H/L Rep 1,,
FS2019_db/db2,,
KS2014_Intensity pY_PV4,,
KBE2022_Log2_Ex_39_U,0.42976547014336985,0.5499502997615039
EP2017_Untreated R#3 log2 ratio,0.4316026234258237,0.5093055815177736
RB2022_2_PostStrength,,
AS2011_Ratio H/L Normalized_1,,
MV2014_Ratio M/H normalized A3___2 (10 min),,
CR2017_Ratio Replicate 3.4,0.4142600877133596,0.5356448460263715
HS2024_8_PD_T2,,
FS2019_Ctr2,,
RB2022_6_PreEndurance,,
FR2021_Norm.Intensity.G,,
NJH2025_Sub9_HIIT_Post,,
CKC2017_log2 normalized phosphoproteomics_0min_rep#3,,
RM2024_Intensity D4-3,,
HS2024_8_B_N1,,
NJH2025_Sub10_MICT_Mid,,
KBE2022_Log2_Ex_15_U,0.42188083138842425,0.5471637186683432
AS2011_Ratio H/L Normalized Inhi_2,,
RKK2015_TNF-α/SC-514,,
RB2022_3_PreSprint,,
CR2017_Ratio Replicate 2.3,0.4153161786766236,0.5309392663137854
RM2009_Ratio M/L Normalized by Corresponding Protein Level (M:15 min timepoint;L:0 min. timepoint),,
CP2009_Ratio H/L Normalized (50 nM dasatinib vs Ctrl),,
GF2025_P4_Adh,,0.5333500217753664
YA2020_Reporter_intensity_Normal_No.2,0.4117165081660118,
YP2020_Intensity P30_R2_mult_log2,,
NJH2025_Sub13_MICT_Post,,
HS2024_4_B_N2,,
HS2024_3_PD_T3,,
AMK2021_120R_p3,,
MV2014_Ratio L/H normalized A3___3 (2 min),,
NJH2025_Sub10_HIIT_Pre,,
FR2021_Intensity.G,,
RAM2015_Log2 C,0.4121416975681703,0.5538822640599975
AS2011_Ratio H/L Proteins Inhi_1,,
FSO2013_Ratio H/M normalized Rep1___3,,
AH2018_LFQ_M_2_N,0.4119864535172734,0.563062071049702
MV2014_Ratio M/L normalized A1___3 (2 min),,
KBE2022_Log2_Ex_40_T,0.4286928642827501,0.5481048759542132
CK2022_2 16-1,,0.5423868200487811
RAM2015_Log2 B,0.4140645019946999,0.5495660083077201
YP2020_Intensity C10_R1_mult_log2,,
FSO2013_Ratio M/L normalized Rep1___2,0.44225786015632285,0.5534806658827142
NJH2025_Sub8_MICT_Pre,,
EJN2021_4_Rest_Basal,,
YB2013_Ratio_H_L_Normalized_in_experiment_2,,
JJ2018_Ratio H/M normalized pP3___1,,
VOI2024_Veh2 mono,,
HS2024_6_B_T1,,
UK2020_HCM_5,,
NJH2025_Sub10_HIIT_Post,,
VOI2024_0.1uM 2 h_3 mono,,
JW2015_Intensity pre3,,
AS2011_Ratio H/L Normalized Inhi_2_1,,
DL2023_24h-3,,
HS2024_7_PD_T3,,
PG2020_Intensity Mock_10h_B,,0.549883576553734
WZ2023_Su_025_30min,0.4067778725004219,0.5586516187976766
AH2018_LFQ_4_N,,0.5580600273387233
CR2017_Ratio Replicate 1.2,0.4198520984463222,0.5529081445540396
AS2011_Ratio H/L Normalized by Proteins,,
RB2022_6_RecoveryStrength,,
HS2024_8_I_N1,,
AMK2021_Ctrl_p3,,
AS2011_Ratio H/L Protein Inhi_2,,
HH2022_Reporter intensity 7,0.43394193438147155,0.5466307790278353
AH2018_SILAC_M_1_X,,0.5510679917869944
RB2022_7_PreEndurance,,
VOI2024_0.1uM 24 h_2 di,,
DL2023_control-2,,
LY2019_P6+,,0.5413696128899341
DB2022_LFQ intensity R2,,
GF2025_P6_Adh,,0.5593148824610481
VOI2024_Veh1 di,,
AS2011_Ratio H/L RNAi_2,,
FSO2012_Ratio -/+ 3-MB-PP1 exp. as3,,
VOI2024_Veh3 mono,,
HS2024_5_I_T2,,
NJH2025_Sub7_HIIT_Mid,,
MV2014_Ratio H/L normalized B1___1 (30 min),,
RM2009_Ratio H/L (H:60 min timepoint;L:0 min. timepoint),,
RB2022_6_PostSprint,,
KTGR2014_Ratio H L Normalized Rep2_Rapamycin_0_15,,
AS2011_Ratio H/L Inhi_1,,
AS2011_Ratio H/L Normalized RNAi_1_2,,
AH2018_TMTMS3_2_C,0.4277781909330927,0.5527859505868351
SR2019_Hs578T_Biol_repl_4,,
RB2022_8_PreStrength,,
KS2014_Intensity C5,0.42780098053403515,0.5549728206458975
RM2024_Intensity D0-1,,
CW2012_10 µM Gef/control Experiment 3 Replicate A,,
YP2020_Intensity P30_R1_mult_log2,,
NJH2025_Sub2_HIIT_Pre,,
RB2022_3_RecoveryEndurance,,
RNJ2017_Log2_ratio_Tstim:Trest_D2,,
GF2025_P9_Adh,,0.5552849905003673
RB2022_3_PostStrength,,
TM2022_S2.8h.A,,
AS2011_Ratio H/L RNAi_1_1,,
AS2011_Ratio H/L Normalized by Proteins RNAi_2,,
FSO2012_Ratio -/+ 3-MB-PP1 exp. wt1,,
AS2011_Ratio H/L Normalized by Protein Inhi_1,,
NJH2025_Sub2_MICT_Pre,,
MV2014_Ratio L/M normalized A2___3 (10 min),,
MV2014_Ratio H/M normalized A2___3 (2 min),,
HS2024_4_B_T2,,
SR2019_BT549_Biol_repl_1,,
AH2018_LFQ_M_4_N,0.41971659198234956,0.5629526706960168
NJH2024_Sub8_HIIT_Mid,,
PG2020_Intensity 8h_B,,0.5231937809071553
AH2018_LFQ_2_X,,0.5550623756601892
PG2020_Intensity 2h_B,,0.5286534051654208
AS2011_Ratio H/L Proteins RNAi_1,,
RB2022_4_PostSprint,,
KS2014_Intensity E15_3,0.42546265392985366,0.559471168588846
GF2025_P3_Sph,,0.5432088012355955
DB2022_LFQ intensity L2,,
MV2014_Ratio H/L normalized A1___1 (10 min),,
AH2018_SILAC_1_C,,0.5505704173468697
NJH2024_Sub1_HIIT_Pre,,
FSO2013_Ratio M/L normalized Rep2___2,0.41095038976764514,0.5263831862219266
NJH2015_TMT Subject 4 130_N/129_C (Exercise/Basal) (normalized),,
AS2011_Ratio H/L RNAi_2_3,,
AH2018_SILAC_IT_1_N,,0.5534619471060492
KTGR2014_Ratio H M Normalized Rep2_AA_starvation_0_15,,
RB2022_4_PreEndurance,,
JJ2018_Ratio M/L normalized pP1,,
CR2017_Ratio Replicate 2.4,0.4392585782779655,0.525005077279235
ZQ2022_N1,,
LY2019_P6-,,0.5434915510654299
RM2024_Intensity D2-3,,
UK2020_HCM_1,,
JW2015_Intensity pre2,,
KTGR2014_Ratio M L Normalized Rep1_AA_starvation_0_15,,
RM2024_Intensity D2-1,,
NJH2025_Sub12_MICT_Post,,
MV2014_Ratio H/M normalized B2___2 (5 min),,
RN2012_L14,0.4277432528367008,
AH2018_LFQ_3_N,,0.5582975915531401
RKK2015_TNF-α/IKKb,,
SFR2015_HL_log2_ratio_std_b,0.44103140519414746,0.5567555101222201
UK2020_UA_1,,
KBE2022_Log2_Ex_13_U,0.4261039197556893,0.549519103485928
AS2011_Ratio H/L Normalized Inhi_1,,
RNJ2017_Log2_ratio_Tsup:Trest_D2,,
RB2022_1_RecoverySprint,,
CKC2017_log2 normalized phosphoproteomics_120min_rep#1,,
JJ2018_Ratio H/L normalized pP3,,
CK2022_7 40-1,,0.5376873394292181
AS2011_Ratio H/L Inhi_1_3,,
NJH2025_Sub10_HIIT_Mid,,
KTGR2014_Ratio H L Normalized Rep2_AA_starvation_0_15,,
JAW2011_Ratio H/L LS1b_1,,
PG2020_Intensity 4h_B,,0.5498173384451874
SR2019_BT549_Biol_repl_2,,
RM2024_Intensity D4-2,,
DB2022_LFQ intensity R2.2,,
JJ2018_Ratio H/L normalized,,
RB2022_5_PostEndurance,,
HS2024_5_PD_T2,,
WZ2023_Su_025_20min,0.40783306305523226,0.5565142285429768
RM2024_Intensity D2-2___1,,
IMM2018_normalised rep. int. CDK5L-2,,
LY2019_P8-,,0.5407462897013013
JVO2010_Ratio H/M Normalized by Protein ThymON - Log2 G2,,
CKC2017_log2 normalized phosphoproteomics_15min_rep#3,,
FSO2013_Ratio H/L normalized Rep1,0.42128292410225326,0.5508173074948661
NJH2024_Sub2_HIIT_Pre,,
CKC2017_log2 normalized phosphoproteomics_60min_rep#2,,
CK2022_13 40-1,,0.5425568633378401
FSO2012_Ratio -/+ 3-MB-PP1 exp. wt4a,,
RN2012_H02,0.41111977264475874,
PG2020_Intensity 10h_D,0.4240394886055358,0.539443413463987
RB2022_8_PreEndurance,,
HS2024_3_B_N2,,
EJN2021_4_Ex_Ins,,
AS2011_Ratio H/L Normalized by Protein,,
EJN2021_1_Ex_Ins,,
EP2017_Pervanadate R#3 log2 ratio,0.44381433195445086,0.5440711233643085
FSO2013_Ratio M/L normalized Rep1___3,,
NJH2025_Sub4_HIIT_Mid,,
RCJD2014_5min_2,,
RB2022_6_PostStrength,,
AH2018_SILAC_MR_3_C,0.4326311977599073,0.5536876101008955
AH2018_LFQ_M_4_C,0.4149848652389144,0.5638680707302093
NJH2024_Sub4_MICT_Pre,,
AS2011_Ratio H/L Normalized Inhi_1_1,,
DL2023_12h-1,,0.5427995112274593
MV2014_Ratio L/M normalized B2___1 (30 min),,
DB2022_LFQ intensity L1.1,,
NJH2025_Sub6_MICT_Pre,,
NJH2025_Sub6_MICT_Post,,
CKC2017_log2 normalized phosphoproteomics_60min_rep#3,,
RN2012_H04,,
CK2022_6 40-1,,0.5387800363265238
DB2022_LFQ intensity R2.1,,
KBE2022_Log2_Ex_42_U,0.4228625190812604,0.5464048861595603
LY2019_P3-,,0.5502426845336809
FR2021_Intensity.A,,
EJN2021_3_Ex_Ins,,
MV2014_Ratio M/L normalized A1___1 (2 min),,
WZ2023_Pe_005_30min,0.4236984935599823,0.5638952501526903
HS2024_8_PD_T3,,
EJN2021_3_Ex_Basal,,
AST2020_Control.1,,0.5536846542880343
JW2015_Intensity cap1,,
PG2020_Intensity CT_A,,0.5510397850203174
FS2019_Ctr3,,
WZ2023_Pu_025_20min,0.41806609539108364,0.5606705186179569
NJH2025_Sub4_MICT_Post,,
JVO2010_Ratio H/M Normalized by Protein Noco3h - Log2 Late S,,
GF2025_P10_Adh,,0.5391811792006573
RB2022_1_RecoveryStrength,,
SR2019_HCC1954_Biol_repl_4,,
FR2021_Norm.Intensity.N,,
HS2024_5_B_N1,,
FSO2013_Ratio H/M normalized Rep3___3,,
AH2018_TMTMS2_2_C,0.4313919223211446,0.5647665683733278
RB2022_4_PreSprint,,
DB2022_Intensity R2,,
AH2018_TMTMS2_Pool,0.42941761441125903,0.5450008365624319
HS2024_8_I_N2,,
RB2022_3_RecoveryStrength,,
NJH2024_Sub6_HIIT_Mid,,
AH2018_SILAC_M_1_C,,0.5491770791118674
LY2019_P8+,,0.5515021833962603
RB2022_2_RecoveryEndurance,,
JJ2018_Ratio H/M normalized pP2___1,,
JAW2011_Ratio H/L HS_1,,
RB2022_3_PostEndurance,,
KS2014_Intensity pY_PV1,,
JAW2011_Ratio H/L LS1b_2,,
SR2019_MCF7_Biol_repl_2,,
NJH2015_TMT Subject 2 128_N/127_C (Exercise/Basal) (normalized),,
AS2011_Ratio H/L Normalized RNAi_1_1,,
AH2018_LFQ_M_4_X,0.4165312613024487,0.5631630799001752
NJH2024_Sub6_MICT_Pre,,
JJ2018_Ratio M/L normalized pP1___2,,
YP2020_Intensity C30_R2_mult_log2,,
NJH2024_Sub9_HIIT_Pre,,
AS2011_Ratio H/L Normalized Inhi_2_3,,
RM2024_Intensity D0-1___3,,
FSO2012_Ratio -/+ 3-MB-PP1 exp. wt3,,
KBE2022_Log2_Ex_28_U,0.43037607663884775,0.5485868348788114
GRW2016_Ratio H/L normalized SILAC 1___1,,
CF2017_FTE 17,,
LY2019_P2-,,0.5286674515886043
AH2018_LFQ_IT_1_X,,0.5505917163752112
JJ2018_Ratio H/L normalized pP3___1,,
RB2022_8_RecoveryStrength,,
WZ2023_Pe_005_20min,0.4196444794663595,0.5640470253005911
AST2020_Control.2,,0.5538985398779486
NJH2025_Sub6_MICT_Mid,,
RCJD2014_10min_1,,
FSO2013_Ratio H/L normalized Rep2___3,,
JVO2010_Ratio M/L Normalized by Protein Noco3h - Log2 G1,,
HS2024_3_I_T1,,
FSO2012_Ratio -/+ 3-MB-PP1 exp. as2a,,
CK2022_4 40-1,,0.5385444749379682
SR2019_MCF10A_Biol_repl_4,,
KS2014_Intensity pY_C5,,
NJH2025_Sub4_MICT_Pre,,
NJH2024_Sub9_MICT_Post,,
CF2017_OSE 28,,
HS2024_5_B_T2,,
HS2024_6_I_T1,,
HS2024_5_B_T3,,
JJ2018_Ratio H/M normalized pP1___1,,
KBE2022_Log2_Ex_36_U,0.4224722760432826,0.5369271187909734
AH2018_TMTMS3_3_N,0.4303987815915374,0.5504775565969304
SR2019_HCC1419_Biol_repl_2,,0.5404878826939544
FR2021_Intensity.N,,
AS2011_Ratio H/L Inhi_2_1,,
AH2018_SILAC_MR_1_C,0.4315678454568398,0.5579340919842742
NJH2024_Sub1_HIIT_Mid,,
NJH2025_Sub8_HIIT_Mid,,
EP2017_Mitotic R#3 log2 ratio,0.4299261510134376,0.5472227984335931
KBE2022_Log2_Ex_36_T,0.4244056875271632,0.5353888736070622
NJH2025_Sub6_HIIT_Mid,,
WZ2023_Pu_005_30min,0.4074171542649669,0.559458165553517
KS2014_Intensity C2,0.4320712260117731,0.5589378955021277
FSO2013_Ratio H/L normalized Rep1___2,0.4218607793447416,0.5397070881403676
RM2024_Intensity D2-2,,
KBE2022_Log2_Ex_42_T,0.4295980706957082,0.5475908512308671
CK2022_9 200-1,,0.5432890343620864
GRW2016_Ratio H/L normalized SILAC 2___1,,
JJ2018_Ratio H/M normalized pP3___2,,
DB2022_LFQ intensity R1.1,,
CK2022_10 200-1,,0.5432830688321174
NJH2024_Sub9_MICT_Mid,,
JAW2011_Ratio H/L_2,,
HS2024_7_I_N2,,
RBK2021_1332T Late,,
LY2019_P1-,,0.5444204568653657
RKK2015_TNF-α/basal.1,,
RKK2015_TNF-α/TNF-α+SC-514,,
CR2017_Ratio Replicate 2.5,0.4133047187138349,0.529432510936241
HS2024_3_I_T3,,
CKC2017_log2 normalized phosphoproteomics_90min_rep#2,,
AS2011_Ratio H/L Normalized RNAi_1,,
KS2014_Intensity E15_4,0.42815638230832115,0.5648450805517808
ZQ2022_C3,,
EJN2021_3_Rest_Ins,,
YP2020_Intensity P10_R2_mult_log2,,
MV2014_Ratio H/L normalized A1___3 (10 min),,
NJH2025_Sub1_MICT_Pre,,
KBE2022_Log2_Ex_39_T,0.432656866799254,0.5499979070437053
FSO2013_Ratio H/M normalized Rep3___2,0.409851797453726,0.525717405909426
RM2024_Intensity D6-2,,
EP2017_Untreated R#1 log2 ratio,0.4357289460048638,0.5300126297075345
RKK2015_SC-514/basal,,
RM2024_Intensity D6-1___3,,
WZ2023_Pu_010_10min,0.4152735151904225,0.5609133585505033
NJH2025_Sub9_HIIT_Mid,,
SR2019_SKBR3_Biol_repl_4,,
HS2024_5_I_T3,,
KS2014_Intensity N1,0.41966004065372464,0.5386751384157304
NJH2024_Sub12_MICT_Post,,
TM2022_S2.8h.C,,
CR2017_Ratio Replicate 1,0.42878203641710033,0.547594014123805
AS2011_RNAi 1_Ratio H/L normalized by corresponding protein level (H: shPlk1; L: shEg5),,
CKC2017_log2 normalized phosphoproteomics_30min_rep#3,,
JJ2018_Ratio H/M normalized pP3,,
AH2018_SILAC_MR_2_C,0.43142931253791045,0.5559515511211706
LATM2013_Log2 Ratio (Medium/Light) Forward,,
PG2020_Intensity 2h_A,,0.5507474375916934
NJH2024_Sub6_MICT_Mid,,
NJH2025_Sub13_HIIT_Post,,
AH2018_SILAC_MR_3_X,0.43210147224665507,0.5611730517264177
JJ2018_Ratio H/M normalized___1,,
RCJD2014_15min_2,,
AS2011_Ratio H/L_2,,
AS2011_Ratio H/L Normalized,,
RN2012_H03,0.43046228574989326,0.5352595488109123
HS2024_5_B_N2,,
HS2024_5_I_N1,,
HS2024_6_I_N1,,
AR2021_KD 48h,,0.5730433180946489
FR2021_Intensity.B,,
RB2022_3_PreEndurance,,
HS2024_5_I_T1,,
NJH2024_Sub10_MICT_Pre,,
SR2019_LM2_Biol_repl_2,,
AST2020_anti-CD3,,0.5541143722507011
SR2019_MDAMB231_Biol_repl_1,,
RM2024_Intensity D2-3___3,,
WZ2023_Pe_005_10min,0.4191245788619636,0.5640233190820407
KBE2022_Log2_Ex_29_U,0.42491929647619886,0.5389685795264938
HS2024_7_B_T1,,
AH2018_LFQ_M_2_X,0.3917270439746415,0.5651486741011171
AH2018_LFQ_IT_4_N,,0.5533936171877766
CK2022_15 200-1,,0.5519702129644235
RM2024_Intensity D4-1___2,,
JJ2018_Ratio H/M normalized,,
JJ2018_Ratio M/L normalized pP3___1,,
KBE2022_Log2_Ex_34_T,0.42739100548176634,0.537340476950898
CKC2017_log2 normalized phosphoproteomics_0min_rep#2,,
LY2019_P2+,,
LATM2013_Log2 Ratio (Light/Medium) Reverse,,
CK2022_2 200-1,,0.5465636311473562
AS2011_Ratio H/L Protein RNAi_2,,
MV2014_Ratio L/H normalized A3___1 (2 min),,
WZ2023_Su_010_30min,0.4097519671734681,0.5616943737526858
RN2012_H01,0.4146496393299839,
KTGR2014_Ratio-Rapa 2 mins,,
EJN2021_2_Rest_Basal,,
KS2014_Intensity pY_E5_3,,
MM2018_Ratio H/L replicate 3,,
EP2017_Pervanadate R#1 normalized log2 ratio,0.44428048630905403,0.5429313066888914
HS2024_8_B_T3,,
YA2020_Reporter_intensity_Cancer_No.3,0.4121805329056617,
KBE2022_Log2_Ex_44_U,0.4258535114484284,0.538966242758635
WZ2023_Pe_010_20min,0.4196553278230935,0.564363885256485
KS2014_Intensity pY_C6,,
AS2011_Ratio H/L Normalized_3,,
RCJD2014_15min_mean,,
RB2022_3_PreStrength,,
NJH2015_iTRAQ Subject 3 116/117 (Exercise/Basal) (normalized),,
RCJD2014_10min_mean,,
KS2014_Intensity C1,0.42322834845060664,0.5680977855553315
FSO2013_Ratio H/M normalized Rep3___1,,0.539708126877001
AH2018_SILAC_M_3_C,,0.5540506930800067
RKK2015_TNF-α+IKKb/TNF-α,,
RM2024_Intensity D0-3___2,,
FSO2012_Ratio -/+ 3-MB-PP1 exp. wt2a,,
AH2018_SILAC_M_2_C,,0.5544909184708152
AH2018_SILAC_M_2_X,,0.5542814667188968
KTGR2014_Ratio-Rapa 15 mins,,
RM2024_Intensity D4-2___1,,
KBE2022_Log2_Ex_15_T,0.4283114079765998,0.5447976992475749
VOI2024_0.1uM 24 h_1 di,,
WZ2023_Su_010_10min,0.4049690531561951,0.5608382681980882
PG2020_Intensity 6h_C,0.4132813439726665,0.5433796032714377
JVO2010_Ratio M/L Normalized by Protein Noco45 - Log2 mitosis,,
JJ2018_Ratio M/L normalized pP1___1,,
AH2018_LFQ_M_3_N,,0.5616535014535157
VOI2024_0.1uM 24 h_2 mono,,
AH2018_TMTMS2_3_C,0.43337136022906797,0.5618749728379735
CK2022_15 16-1,,0.5450298222033317
CK2022_3 16-1,,0.539804763266279
LY2019_P4-,,0.5542092631400443
FSO2013_Ratio H/L normalized Rep3___2,0.4223973165299822,0.5385116652687019
KS2014_Intensity pY_PV2,,
HS2024_3_I_N2,,
GF2025_P8_Adh,,0.5581815355809899
YC2018_Log2(SKBR3-LR/SKBR3)_Rep.2-2,,
GF2025_P5_Sph,,0.5417215617142535
CK2022_10 16-1,,0.536511812672437
KTGR2014_Ratio H L Normalized Rep1_AA_starvation_0_15,,
VOI2024_0.1uM 2 h_2 di,,
NJH2015_TMT Pool 131/130_C (Exercise/Basal) (normalized),,
NJH2024_Sub2_HIIT_Mid,,
AMK2021_45I_p3,,
NJH2024_Sub13_HIIT_Mid,,
DB2022_LFQ intensity R1.2,,
DB2022_Intensity R1,,
NJH2024_Sub12_MICT_Mid,,
KTGR2014_Ratio M L Normalized Rep1_Rapamycin_0_15,,
UK2020_HCM_4,,
SAS2015_AZD/DMSO_Exp2,,
IMM2018_normalised rep. int. CDK5L-1,,
DB2022_LFQ intensity L2.2,,
KTGR2014_Ratio H M Normalized Rep1_AA_starvation_0_15,,
EP2017_Mitotic R#1 log2 ratio,0.4326181202935677,0.5379342472881125
EJN2021_2_Ex_Basal,,
RM2009_Ratio H/L Normalized by Corresponding Protein Level (H:60 min timepoint;L:0 min. timepoint),,
KTGR2014_Ratio-Rapa 30 mins,,
CKC2017_log2 normalized phosphoproteomics_90min_rep#1,,
CF2017_FTE 16,,0.543634380614065
AR2021_L41 10 μM,,0.5609285275716231
CF2017_EOC 2,,
RB2022_6_PostEndurance,,
AH2018_SILAC_1_N,,0.5520693121932011
NJH2024_Sub10_HIIT_Pre,,
AS2011_Ratio H/L Inhi_1_2,,
UK2020_HCM_6,,
RB2022_7_PreSprint,,
NJH2024_Sub2_MICT_Pre,,
HS2024_3_PD_T2,,
CK2022_6 16-1,,0.5407364936647958
ZX2022_CB treated Replicate 1,,0.5484151272899132
BS2014_Log2(Ratio H/L normalized Rep_3),,
TM2022_mock.12h.C,,
GRW2016_Ratio M/L normalized SILAC 5a___1,,
HH2022_Reporter intensity 0,0.4109378669072153,0.5493752960405199
RM2024_Intensity D2-2___2,,
JC2019_Normalised_intensity_B_TiOx_Testis_sample_URO0126,,
RB2022_1_PreStrength,,
JJ2018_Ratio H/M normalized pP2___2,,
AH2018_TMTMS2_2_X,0.43631236688907027,0.5619566253280476
AR2021_L41 1 μM,,0.541493850295232
JJ2018_Ratio H/M normalized pP1___2,,
AH2018_TMTMS2_1_N,0.4363382178993634,0.5597449243800151
NJH2025_Sub10_MICT_Pre,,
JVO2010_Ratio H/M Normalized by Protein Noco45 - Log2 early S,,
ZX2022_Control Replicate 3,,0.5475250037759598
KS2014_Intensity C4,,0.5630562179397544
AS2011_Ratio H/L Inhi_2,,
KBE2022_Log2_Ex_18_T,0.4414244042745408,0.53594695800653
NJH2025_Sub9_MICT_Pre,,
RCJD2014_20min_1,,
MV2014_Ratio H/M normalized B2___1 (5 min),,
FSO2013_Ratio M/L normalized Rep2___3,,
JC2019_Normalised_intensity_C_TiOx_Testis_sample_URO0158,,
SR2019_MCF10A_Biol_repl_3,,0.5395642798881799
HS2024_7_B_T2,,
SAS2015_PLX/DMSO_Exp3,,
AMK2021_Ctrl_p5,,
NJH2025_Sub2_HIIT_Mid,,
AH2018_LFQ_M_3_C,,0.5575389246522585
CKC2017_log2 normalized phosphoproteomics_15min_rep#2,,
YA2020_Reporter_intensity_Cancer_No.2,0.41619506689418967,
FSO2013_Ratio H/M normalized Rep2___3,,
RB2022_8_PreSprint,,
AH2018_SILAC_IT_3_C,,0.5557544336160742
WZ2023_Pu_025_10min,0.4179152734602455,0.5609589441159177
RM2024_Intensity D2-2___3,,
AS2011_Ratio H/L_1,,
RCJD2014_10min_3,,
FSO2013_Ratio M/L normalized Rep3___1,,0.5427955891814322
SR2019_JIMT1_Biol_repl_4,,0.5373765238236179
YP2020_Intensity C10_R2_mult_log2,,
ZCP2016_Ratio H/L Rep 2,,
CF2017_EOC 4,,
JJ2018_Ratio H/L normalized pP1___1,,
WZ2023_Pe_010_30min,0.42081380626818155,0.5642302078658644
MV2014_Ratio L/M normalized B2___3 (30 min),,
AH2018_LFQ_IT_3_N,,0.5534216111251593
KS2014_Intensity C6,0.43435038656591035,0.5474460755265088
ZQ2022_N3,,
HW2015_Ratio H/L normalized Exp1,,
CK2022_12 40-1,,0.537058925056877
NJH2024_Sub7_MICT_Pre,,
ZX2022_Control Replicate 1,,0.5494100070270508
JJ2018_Ratio H/M normalized pP1,,
CK2022_16 40-1,,0.5435790307744397
AH2018_SILAC_IT_2_C,,0.5546190370588786
CK2022_5 40-1,,0.5385695331483777
AH2018_LFQ_3_X,,0.5601848185416272
UK2020_UA_3,,
LY2019_P7-,,0.5410645089349038
GF2025_P5_Adh,,0.5416302719925132
RB2022_1_PostStrength,,
JAW2011_Ratio H/L LS1b,,
FSO2013_Ratio H/L normalized Rep3___1,,0.5426098804542441
SR2019_HCC1954_Biol_repl_3,,
CR2017_Ratio Replicate 2.2,0.41416646342028285,0.5575428280797822
VOI2024_0.1uM 2 h_1 mono,,
MV2014_Ratio L/M normalized A2___1 (10 min),,
RNJ2017_Log2_ratio_Tsup:Tstim_D3,,
CK2022_11 16-1,,0.5379559935462902
ZQ2022_C1,,
CR2017_Ratio Replicate 2.1,0.40838526599370273,0.542308166767846
PG2020_Intensity CT_B,,0.5388249429630492
JJ2018_Ratio M/L normalized___2,,
AH2018_SILAC_MR_1_N,0.40599219584413043,0.5572708933985661
KS2014_Intensity pY_E5_1,,
JW2021_Before_3,,
NJH2015_iTRAQ Subject 2 117/116 (Exercise/Basal) (normalized),,
MV2014_Ratio M/H normalized B3___3 (30 min),,
FS2019_db/db1,,
NJH2025_Sub9_HIIT_Pre,,
JAW2011_Ratio H/L_1,,
RCJD2014_20min_3,,
AH2018_LFQ_3_C,,0.5534910295839044
JJ2018_Ratio M/L normalized pP3___2,,
AMK2021_45I_p1,,
NJH2025_Sub8_HIIT_Post,,
AH2018_LFQ_M_3_X,,0.5647914230216973
YA2020_Reporter_intensity_Cancer_No.4,0.4117242948733354,
KS2014_Intensity pY_E5_2,,0.5401077004262467
FSO2013_Ratio H/L normalized Rep1___3,,
GF2025_P4_Sph,,0.5382205828970863
RB2022_2_PreEndurance,,
JW2021_Before_1,,
KBE2022_Log2_Ex_25_T,0.429713084036755,0.5553468087690112
AS2011_Ratio H/L Normalized by Proteins Inhi_2,,
MV2014_Ratio L/M normalized A2___2 (10 min),,
JJ2018_Ratio M/L normalized___1,,
FR2021_Intensity.H,,
CK2022_14 16-1,,0.5438928903584423
AST2020_anti-CD3+PDL2,,0.5538860733095702
MV2014_Ratio M/L normalized B1___1 (5 min),,
KBE2022_Log2_Ex_19_T,0.42450088456510066,0.5472402693345273
KS2014_Intensity pY_N1,,
RB2022_1_RecoveryEndurance,,
FSO2013_Ratio H/M normalized Rep1___2,0.42351193141031834,0.5425345414739778
HS2024_8_I_T1,,
NJH2015_iTRAQ Subject 1 115/114 (Exercise/Basal) (normalized),,
EP2017_Mitotic R#2 log2 ratio,0.4306947177722682,0.5454177991653141
AH2018_TMTMS2_1_X,0.43606840797577984,0.5511162592844862
KTGR2014_Ratio M L Normalized Rep2_AA_starvation_0_15,,
ZCP2016_Ratio H/L Rep 3,,
AS2011_Ratio H/L Normalized RNAi_1_3,,
SR2019_MCF10A_Biol_repl_1,,
NJH2025_Sub8_MICT_Mid,,
EJN2021_5_Ex_Ins,,
HS2024_6_I_N2,,
HH2022_Reporter intensity 4,0.4364002381484042,
RBK2021_1326T Late,,
TM2022_mock.12h.B,,
NJH2024_Sub12_MICT_Pre,,
RCJD2014_15min_3,,
MV2014_Ratio L/H normalized B3___2 (5 min),,
LG2023_Control-3_intensity,,
JJ2018_Ratio H/L normalized pP3___2,,
CF2017_FTE 15,,0.5430702774951479
HS2024_4_I_T3,,
AH2018_SILAC_1_X,,0.5505755123330531
PG2020_Intensity 10h_B,0.4135640091658656,0.5382497110897179
AH2018_TMTMS3_1_X,0.42934413816471767,0.5448444755164045
CF2017_FTE 14,,0.5407225775509601
NJH2024_Sub13_HIIT_Post,,
RM2024_Intensity D6-3___3,,
NJH2025_Sub7_HIIT_Pre,,
RBK2021_1259T Early,,
RKK2015_IKK+TNF-α/IKKb,,
FSO2012_Ratio -/+ 3-MB-PP1 exp. as1b,,
PG2020_Intensity 6h_A,,0.5430376722573302
SR2019_HCC1419_Biol_repl_3,,0.5379166224293785
KBE2022_Log2_Ex_14_T,0.4267489749102963,0.5485818728601115
EP2017_Untreated R#2 normalized log2 ratio,0.42564334085039607,0.5769492544119996
RM2024_Intensity D0-2___1,,
DB2022_Intensity L1,,
LY2019_P5+,,0.5477035096007568
HS2024_5_I_N2,,
SAS2015_PLX/AZD_Exp3,,
EP2017_Pervanadate R#2 log2 ratio,0.4457215392662869,0.5586433766982876
AS2011_Ratio H/L Normalized RNAi_2_1,,
